DOCSLIB.ORG

Wolfe2007.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Wolfe2007.Pdf INFECTION AND IMMUNITY, Oct. 2007, p. 4972–4979 Vol. 75, No. 10 0019-9567/07/$08.00ϩ0 doi:10.1128/IAI.00763-07 Copyright © 2007, American Society for Microbiology. All Rights Reserved. The O Antigen Enables Bordetella parapertussis To Avoid Bordetella pertussis-Induced Immunityᰔ Daniel N. Wolfe,1 Elizabeth M. Goebel,2 Ottar N. Bjornstad,3 Olivier Restif,4 and Eric T. Harvill1* Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, 115 Henning Building, University Park, Pennsylvania 168021; Huck Institute of Life Sciences, The Pennsylvania State University, 519 Wartik Lab, University Park, Pennsylvania 168022; Departments of Entomology and Biology, The Pennsylvania State University, 501 Agricultural Sciences and Industry Building, University Park, Pennsylvania 168023; and Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 OES, Great Britain4 Received 5 June 2007/Returned for modification 18 July 2007/Accepted 1 August 2007 Bordetella pertussis and Bordetella parapertussis are closely related endemic human pathogens which cause whooping cough, a disease that is reemerging in human populations. Despite how closely related these pathogens are, their coexistence and the limited efficacy of B. pertussis vaccines against B. parapertussis suggest a lack of cross-protective immunity between the two. We sought to address the ability of infection-induced Downloaded from immunity against one of these pathogens to protect against subsequent infection by the other using a mouse model of infection. Immunity induced by B. parapertussis infection protected against subsequent infections by either species. However, immunity induced by B. pertussis infection prevented subsequent B. pertussis infections but did not protect against B. parapertussis infections. The O antigen of B. parapertussis inhibited binding of antibodies to the bacterial surface and was required for B. parapertussis to colonize mice convalescent from B. pertussis infection. Thus, the O antigen of B. parapertussis confers asymmetrical cross-immunity between the iai.asm.org causative agents of whooping cough. We propose that these findings warrant investigation of the relative role of B. parapertussis in the resurgence of whooping cough. at Penn State Univ on September 20, 2007 Bordetella pertussis and Bordetella parapertussis are the caus- progenitor, Bordetella bronchiseptica, and share the majority of ative agents of whooping cough (21, 37), a disease that is their virulence factors (42), cross-immunity could be expected. endemic worldwide despite extensive vaccination efforts (48). Furthermore, genetic comparisons of B. pertussis and B. para- Upon the introduction of B. pertussis vaccines more than 50 pertussis to B. bronchiseptica suggest that B. parapertussis years ago, the incidence of whooping cough greatly declined in emerged as a pathogen more recently than B. pertussis (28, 35, developed countries (9). However, the incidence of this disease 42). Since the mean age at the time of primary B. pertussis has been steadily rising over the past 10 to 20 years in popu- infection for unvaccinated children is less than 5 years (9) and lations despite excellent vaccine coverage (7, 8, 12, 49, 56). infection-induced immunity is protective 5 to 10 years (60), it Although disease caused by B. parapertussis may be less is likely that B. parapertussis successfully emerged in popula- severe than that caused by B. pertussis, infections by these tions that had some level of immunity to B. pertussis (4). bacteria are clinically indistinguishable except for an acute Although adapted to humans, both organisms efficiently col- lymphocytosis that is observed only upon infection of naive onize and rapidly grow throughout the murine respiratory tract hosts by B. pertussis (3, 21, 36, 41). Differentiating between but are ultimately eliminated from the lower respiratory tract these pathogens requires costly laboratory work that does not by B- and T-cell-dependent immunity (24, 25, 27, 62). Wa- affect treatment decisions (37), making differential diagnoses tanabe and Nagai suggested that an immune response induced rare. When specifically investigated, B. parapertussis has been by one species conferred efficient protection against infections found to cause anywhere from less than 1 percent to greater by either species (58). However, bacterial numbers were quan- than 95 percent of whooping cough cases (reviewed in refer- tified only 2 weeks postinoculation, when bacterial numbers ence 59). Thus, it is unclear how many of the estimated 50 were significantly reduced even in the respiratory tracts of million annual cases of whooping cough (10) may be due to B. naive hosts (25, 58). Additionally, the strain used in that study parapertussis and whether or not this pathogen is contributing B. pertussis to the resurgence of this disease. (18-323) is quite distinct from other strains, as The coexistence of these two species in human populations shown by multilocus enzyme electrophoresis and multilocus creates a paradox to the ecological theory that two closely sequence typing (13, 55), and may actually be more closely related immunizing pathogens cannot occupy the same host related to B. bronchiseptica and B. parapertussis strains than population if immunity is cross-protective (1, 14, 16, 30). Be- other B. pertussis strains (2, 40). These problems, along with cause B. pertussis and B. parapertussis evolved from a common clinical studies showing that B. pertussis vaccines poorly protect against B. parapertussis and that these two organisms coexist in the same populations, led us to investigate cross-protective * Corresponding author. Mailing address: Department of Veteri- immunity between these two pathogens. nary and Biomedical Sciences, The Pennsylvania State University, 115 We sought to determine whether or not B. pertussis and B. Henning Building, University Park, PA 16802. Phone: (814) 863-8522. Fax: (814) 863-6140. E-mail: [email protected]. parapertussis induced effective cross-immunity using the se- ᰔ Published ahead of print on 13 August 2007. quenced prototype strains Tohama I (B. pertussis) (42) and 12822 4972 VOL. 75, 2007 B. PARAPERTUSSIS EVADES CROSS-IMMUNITY 4973 (B. parapertussis) (42), which are indistinguishable from current Western blots. Westerns blotting was performed on lysates containing 1 ϫ 108 isolates by multilocus enzyme electrophoresis and multilo- CFU of heat-killed B. pertussis or B. parapertussis. Lysates were run on 7% cus sequence typing (13, 55). B. parapertussis-induced im- sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels in denaturing conditions. Membranes were probed with serum from B. pertussis-orB. para- munity protected against both species; however, B. pertussis- pertussis-infected mice at a 1:100 dilution and goat anti-mouse (immunoglobulin induced immunity protected only against B. pertussis infection. heavy plus light chains) horseradish peroxidase-conjugated antibody (Southern The asymmetrical cross-immunity appeared to be the result of Biotech, Birmingham, AL) (at a dilution of 1:15,000) as the detector antibody. inefficient binding of B. pertussis-induced antibodies to B. para- The membrane was visualized with ECL Western blotting detection reagents (Amersham Biosciences, Piscataway, NJ). pertussis. O antigen prevented B. pertussis-induced antibodies Statistical analysis. The means Ϯ standard deviations (error bars) were de- from binding to B. parapertussis in vitro and from clearing the termined for CFU, IFN-␥ production, and antibody titers. Two-tailed, unpaired bacteria from the respiratory tract in vivo. Together these data Student t tests were used to determine statistical significance between groups. provide a molecular basis for the ability of B. parapertussis to Results were also analyzed by nonparametric Mann-Whitney tests with similar avoid B. pertussis-induced immunity, an ability that may be critical significance. All experiments were performed at least twice with similar results. to the coexistence of these pathogens in human populations. RESULTS MATERIALS AND METHODS Cross-immunity between B. pertussis and B. parapertussis is Bacterial strains and growth. B. pertussis strains 536 and 536NaI (from Duncan asymmetrical. The coexistence of B. pertussis and B. paraper- Maskell, University of Cambridge, United Kingdom) are streptomycin- and Downloaded from nalidixic acid-resistant derivatives of Tohama I, respectively (51). B. parapertussis tussis in humans led us to assess the ability of these pathogens strain 12822 has been described previously (20), and 12822G is a gentamicin- to induce cross-protective immunity. Although considered hu- resistant derivative of the parent strain (62). B. parapertussis strains CN2591 man-adapted pathogens, both species efficiently colonize the (wild type) and CN2591⌬wbm (O antigen deficient) have previously been de- murine respiratory tract (17, 18) and induce sterilizing protec- scribed (44). All were maintained on Bordet-Gengou agar (Difco) containing tive immunity (25), allowing us to test cross-protection in a 10% defibrinated sheep blood (Hema Resources) and appropriate antibiotics. Liquid-culture bacteria were grown at 37°C overnight on a roller drum to mid-log mouse model. Mice were left uninfected or inoculated with B. phase in Stainer-Scholte broth. pertussis or B. parapertussis. Twenty-eight days later, when iai.asm.org Animal experiments. C57BL/6 mice were obtained from Jackson Laboratories strong immune responses had been generated
Load more

Recommended publications
  • Official Nh Dhhs Health Alert
    THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network [email protected] May 18, 2018, 1300 EDT (1:00 PM EDT) NH-HAN 20180518 Tickborne Diseases in New Hampshire Key Points and Recommendations: 1. Blacklegged ticks transmit at least five different infections in New Hampshire (NH): Lyme disease, Anaplasma, Babesia, Powassan virus, and Borrelia miyamotoi. 2. NH has one of the highest rates of Lyme disease in the nation, and 50-60% of blacklegged ticks sampled from across NH have been found to be infected with Borrelia burgdorferi, the bacterium that causes Lyme disease. 3. NH has experienced a significant increase in human cases of anaplasmosis, with cases more than doubling from 2016 to 2017. The reason for the increase is unknown at this time. 4. The number of new cases of babesiosis also increased in 2017; because Babesia can be transmitted through blood transfusions in addition to tick bites, providers should ask patients with suspected babesiosis whether they have donated blood or received a blood transfusion. 5. Powassan is a newer tickborne disease which has been identified in three NH residents during past seasons in 2013, 2016 and 2017. While uncommon, Powassan can cause a debilitating neurological illness, so providers should maintain an index of suspicion for patients presenting with an unexplained meningoencephalitis. 6. Borrelia miyamotoi infection usually presents with a nonspecific febrile illness similar to other tickborne diseases like anaplasmosis, and has recently been identified in one NH resident. Tests for Lyme disease do not reliably detect Borrelia miyamotoi, so providers should consider specific testing for Borrelia miyamotoi (see Attachment 1) and other pathogens if testing for Lyme disease is negative but a tickborne disease is still suspected.
    [Show full text]
  • Iron Is an Essential Nutrient 4 Bacteria and Humans
    Abstract The bhuTUV and bhuO genes play vital roles in the ability of Brucella abortus to use heme as an iron source and are regulated in an iron-responsive manner by RirA and Irr by Jenifer F. Ojeda April, 2012 Dissertation Advisor: RM Roop II Department of Microbiology and Immunology Brucella abortus is a Gram negative intracellular pathogen that causes the zoonotic disease brucellosis. Antibiotic treatment for brucellosis in humans is prolonged and sometimes followed by relapses. Currently, the United States employs prevention of the illness in humans through cattle vaccinations, eliminating the bacterium in its natural host. Unfortunately, these vaccine strains cause the disease in humans, and Brucella research ultimately aims to identify new vaccine targets as well as alternative treatment options. Brucella abortus resides in the phagosomal compartment of the host macrophage where essential nutrients such as iron are limited. Most bacteria need iron, and within the macrophage, heme is a likely source of iron due to the breakdown of red blood cells by the host macrophage. Heme transporters in Gram negative bacteria are highly conserved, and include components for outer membrane, periplasmic, and cytoplasmic membrane transport. BhuA has been previously characterized as the outer membrane heme transporter of Brucella abortus and here we report that BhuT, BhuU, and BhuV (BhuTUV) are the periplasmic and cytoplasmic heme transport components and that they are required in order for Brucella abortus to transport heme as an iron source. Utilization of heme as an iron source requires the breakdown of heme into ferrous iron, carbon monoxide, and biliverdin by a heme oxygenase.
    [Show full text]
  • BD-CS-057, REV 0 | AUGUST 2017 | Page 1
    EXPLIFY RESPIRATORY PATHOGENS BY NEXT GENERATION SEQUENCING Limitations Negative results do not rule out viral, bacterial, or fungal infections. Targeted, PCR-based tests are generally more sensitive and are preferred when specific pathogens are suspected, especially for DNA viruses (Adenovirus, CMV, HHV6, HSV, and VZV), mycobacteria, and fungi. The analytical sensitivity of this test depends on the cellularity of the sample and the concentration of all microbes present. Analytical sensitivity is assessed using Internal Controls that are added to each sample. Sequencing data for Internal Controls is quantified. Samples with Internal Control values below the validated minimum may have reduced analytical sensitivity or contain inhibitors and are reported as ‘Reduced Analytical Sensitivity’. Additional respiratory pathogens to those reported cannot be excluded in samples with ‘Reduced Analytical Sensitivity’. Due to the complexity of next generation sequencing methodologies, there may be a risk of false-positive results. Contamination with organisms from the upper respiratory tract during specimen collection can also occur. The detection of viral, bacterial, and fungal nucleic acid does not imply organisms causing invasive infection. Results from this test need to be interpreted in conjunction with the clinical history, results of other laboratory tests, epidemiologic information, and other available data. Confirmation of positive results by an alternate method may be indicated in select cases. Validated Organisms BACTERIA Achromobacter
    [Show full text]
  • Phenotypic and Genomic Analyses of Burkholderia Stabilis Clinical Contamination, Switzerland Helena M.B
    RESEARCH Phenotypic and Genomic Analyses of Burkholderia stabilis Clinical Contamination, Switzerland Helena M.B. Seth-Smith, Carlo Casanova, Rami Sommerstein, Dominik M. Meinel,1 Mohamed M.H. Abdelbary,2 Dominique S. Blanc, Sara Droz, Urs Führer, Reto Lienhard, Claudia Lang, Olivier Dubuis, Matthias Schlegel, Andreas Widmer, Peter M. Keller,3 Jonas Marschall, Adrian Egli A recent hospital outbreak related to premoistened gloves pathogens that generally fall within the B. cepacia com- used to wash patients exposed the difficulties of defining plex (Bcc) (1). Burkholderia bacteria have large, flexible, Burkholderia species in clinical settings. The outbreak strain multi-replicon genomes, a large metabolic repertoire, vari- displayed key B. stabilis phenotypes, including the inabil- ous virulence factors, and inherent resistance to many anti- ity to grow at 42°C; we used whole-genome sequencing to microbial drugs (2,3). confirm the pathogen was B. stabilis. The outbreak strain An outbreak of B. stabilis was identified among hos- genome comprises 3 chromosomes and a plasmid, shar- ing an average nucleotide identity of 98.4% with B. stabilis pitalized patients across several cantons in Switzerland ATCC27515 BAA-67, but with 13% novel coding sequenc- during 2015–2016 (4). The bacterium caused bloodstream es. The genome lacks identifiable virulence factors and has infections, noninvasive infections, and wound contamina- no apparent increase in encoded antimicrobial drug resis- tions. The source of the infection was traced to contaminat- tance, few insertion sequences, and few pseudogenes, ed commercially available, premoistened washing gloves suggesting this outbreak was an opportunistic infection by used for bedridden patients. After hospitals discontinued an environmental strain not adapted to human pathogenic- use of these gloves, the outbreak resolved.
    [Show full text]
  • Package Inserts
    Individuals using assistive technology may not be able to fully access the information contained in this file. For assistance, please send an e-mail to: [email protected] and include 508 Accommodation and the title of the document in the subject line of your e-mail. HIGHLIGHTS OF PRESCRIBING INFORMATION -----------------------WARNINGS AND PRECAUTIONS------------------------ These highlights do not include all the information needed to use • Carefully consider benefits and risks before administering VAXELIS to VAXELIS safely and effectively. See full prescribing information for persons with a history of: VAXELIS. - fever ≥40.5°C (≥105°F), hypotonic-hyporesponsive episode (HHE) or VAXELISTM (Diphtheria and Tetanus Toxoids and Acellular Pertussis, persistent, inconsolable crying lasting ≥3 hours within 48 hours after a Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B previous pertussis-containing vaccine. (5.2) Vaccine) - seizures within 3 days after a previous pertussis-containing vaccine. (5.2) Suspension for Intramuscular Injection Initial U.S. Approval: 2018 • If Guillain-Barré syndrome occurred within 6 weeks of receipt of a prior vaccine containing tetanus toxoid, the risk for Guillain-Barré syndrome ----------------------------RECENT MAJOR CHANGES ------------------------ may be increased following VAXELIS. (5.3) Dosage and Administration (2.2) 09/2020 • Apnea following intramuscular vaccination has been observed in some ----------------------------INDICATIONS AND USAGE--------------------------- infants born prematurely. The decision about when to administer an VAXELIS is a vaccine indicated for active immunization to prevent intramuscular vaccine, including VAXELIS, to an infant born prematurely diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease should be based on consideration of the individual infant’s medical status due to Haemophilus influenzae type b.
    [Show full text]
  • Insights Into the Pathogenicity of Burkholderia Pseudomallei
    REVIEWS Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei W. Joost Wiersinga*, Tom van der Poll*, Nicholas J. White‡§, Nicholas P. Day‡§ and Sharon J. Peacock‡§ Abstract | Burkholderia pseudomallei is a potential bioterror agent and the causative agent of melioidosis, a severe disease that is endemic in areas of Southeast Asia and Northern Australia. Infection is often associated with bacterial dissemination to distant sites, and there are many possible disease manifestations, with melioidosis septic shock being the most severe. Eradication of the organism following infection is difficult, with a slow fever-clearance time, the need for prolonged antibiotic therapy and a high rate of relapse if therapy is not completed. Mortality from melioidosis septic shock remains high despite appropriate antimicrobial therapy. Prevention of disease and a reduction in mortality and the rate of relapse are priority areas for future research efforts. Studying how the disease is acquired and the host–pathogen interactions involved will underpin these efforts; this review presents an overview of current knowledge in these areas, highlighting key topics for evaluation. Melioidosis is a serious disease caused by the aerobic, rifamycins, colistin and aminoglycosides), but is usually Gram-negative soil-dwelling bacillus Burkholderia pseu- susceptible to amoxicillin-clavulanate, chloramphenicol, domallei and is most common in Southeast Asia and doxycycline, trimethoprim-sulphamethoxazole, ureido- Northern Australia. Melioidosis is responsible for 20% of penicillins, ceftazidime and carbapenems2,4. Treatment all community-acquired septicaemias and 40% of sepsis- is required for 20 weeks and is divided into intravenous related mortality in northeast Thailand. Reported cases are and oral phases2,4. Initial intravenous therapy is given likely to represent ‘the tip of the iceberg’1,2, as confirmation for 10–14 days; ceftazidime or a carbapenem are the of disease depends on bacterial isolation, a technique that drugs of choice.
    [Show full text]
  • Pseudomonas Aeruginosa1
    The Journal of Immunology IL-17 Is a Critical Component of Vaccine-Induced Protection against Lung Infection by Lipopolysaccharide-Heterologous Strains of Pseudomonas aeruginosa1 Gregory P. Priebe,2*†‡ Rebecca L. Walsh,* Terra A. Cederroth,* Akinobu Kamei,* Yamara S. Coutinho-Sledge,* Joanna B. Goldberg,§ and Gerald B. Pier*‡ In a murine model of acute fatal pneumonia, we previously showed that nasal immunization with a live-attenuated aroA deletant of Pseudomonas aeruginosa strain PAO1 elicited LPS serogroup-specific protection, indicating that opsonic Ab to the LPS O Ag was the most important immune effector. Because P. aeruginosa strain PA14 possesses additional virulence factors, we hypoth- esized that a live-attenuated vaccine based on PA14 might elicit a broader array of immune effectors. Thus, an aroA deletant of PA14, denoted PA14⌬aroA, was constructed. PA14⌬aroA-immunized mice were protected against lethal pneumonia caused not only by the parental strain but also by cytotoxic variants of the O Ag-heterologous P. aeruginosa strains PAO1 and PAO6a,d. Remarkably, serum from PA14⌬aroA-immunized mice had very low levels of opsonic activity against strain PAO1 and could not passively transfer protection, suggesting that an antibody-independent mechanism was needed for the observed cross-serogroup protection. Compared with control mice, PA14⌬aroA-immunized mice had more rapid recruitment of neutrophils to the airways early after challenge. T cells isolated from P. aeruginosa ⌬aroA-immunized mice proliferated and produced IL-17 in high quan- tities after coculture with gentamicin-killed P. aeruginosa. Six hours following challenge, PA14⌬aroA-immunized mice had sig- nificantly higher levels of IL-17 in bronchoalveolar lavage fluid compared with unimmunized, Escherichia coli-immunized, or PAO1⌬aroA-immunized mice.
    [Show full text]
  • Identification of Bordetella Spp. in Respiratory Specimens From
    504 Clinical Microbiology and Infection, Volume 14 Number 5, May 2008 isolates of extended-spectrum-beta-lactamase-producing Original Submission: 27 October 2007; Revised Sub- Shigella sonnei. Ann Trop Med Parasitol 2007; 101: 511–517. mission: 5 December 2007; Accepted: 19 December 21. Rice LB. Controlling antibiotic resistance in the ICU: 2007 different bacteria, different strategies. Cleve Clin J Med 2003; 70: 793–800. Clin Microbiol Infect 2008; 14: 504–506 22. Boyd DA, Tyler S, Christianson S et al. Complete nucleo- 10.1111/j.1469-0691.2008.01968.x tide sequence of a 92-kilobase plasmid harbouring the CTX-M-15 extended spectrum b-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Cystic fibrosis (CF) is an autosomal recessive Antimicrob Agents Chemother 2004; 48: 3758–3764. disease, characterised by defective chloride ion channels that result in multi-organ dysfunction, most notably affecting the respiratory tract. The RESEARCH NOTE alteration in the pulmonary environment is asso- ciated with increased susceptibility to bacterial infection. Recent advances in bacterial taxonomy and improved microbial identification systems Identification of Bordetella spp. in have led to an increasing recognition of the respiratory specimens from individuals diversity of bacterial species involved in CF lung with cystic fibrosis infection. Many such species are opportunistic T. Spilker, A. A. Liwienski and J. J. LiPuma human pathogens, some of which are rarely found in other human infections [1]. Processing Department of Pediatrics and Communicable of CF respiratory cultures therefore employs Diseases, University of Michigan Medical selective media and focuses on detection of School, Ann Arbor, MI, USA uncommon human pathogens.
    [Show full text]
  • Helicobacter Spp. — Food- Or Waterborne Pathogens?
    FRI FOOD SAFETY REVIEWS Helicobacter spp. — Food- or Waterborne Pathogens? M. Ellin Doyle Food Research Institute University of Wisconsin–Madison Madison WI 53706 Contents34B Introduction....................................................................................................................................1 Virulence Factors ...........................................................................................................................2 Associated Diseases .......................................................................................................................2 Gastrointestinal Disease .........................................................................................................2 Neurological Disease..............................................................................................................3 Other Diseases........................................................................................................................4 Epidemiology.................................................................................................................................4 Prevalence..............................................................................................................................4 Transmission ..........................................................................................................................4 Summary .......................................................................................................................................5
    [Show full text]
  • Metagenomics Analysis Reveals the Microbial Communities
    diversity Article Metagenomics Analysis Reveals the Microbial Communities, Antimicrobial Resistance Gene Diversity and Potential Pathogen Transmission Risk of Two Different Landfills in China Shan Wan 1,†, Min Xia 2,†, Jie Tao 1, Yanjun Pang 1, Fugen Yu 1,* , Jun Wu 3,* and Shanping Chen 2,* 1 State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China; [email protected] (S.W.); [email protected] (J.T.); [email protected] (Y.P.) 2 Shanghai Environmental Sanitation Engineering Design Institute Co., Ltd., Shanghai 200232, China; [email protected] 3 State Key Laboratory of Pollution Control and Resource Reuse, School of Environment, Nanjing University, Nanjing 210023, China * Correspondence: [email protected] (F.Y.); [email protected] (J.W.); [email protected] (S.C.) † There authors contribute equally to this work. Abstract: In this study, we used a metagenomic approach to analyze microbial communities, antibiotic resistance gene diversity, and human pathogenic bacterium composition in two typical Citation: Wan, S.; Xia, M.; Tao, J.; landfills in China. Results showed that the phyla Proteobacteria, Bacteroidetes, and Actinobacte- Pang, Y.; Yu, F.; Wu, J.; Chen, S. ria were predominant in the two landfills, and archaea and fungi were also detected. The genera Metagenomics Analysis Reveals the Methanoculleus, Lysobacter, and Pseudomonas were predominantly present in all samples. sul2, sul1, Microbial Communities, tetX, and adeF were the four most abundant antibiotic resistance genes. Sixty-nine bacterial pathogens Antimicrobial Resistance Gene were identified from the two landfills, with Klebsiella pneumoniae, Bordetella pertussis, Pseudomonas Diversity and Potential Pathogen aeruginosa, and Bacillus cereus as the major pathogenic microorganisms, indicating the existence of Transmission Risk of Two Different potential environmental risk in landfills.
    [Show full text]
  • Structural and Functional Effects of Bordetella Avium Infection in the Turkey Respiratory Tract William George Van Alstine Iowa State University
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1987 Structural and functional effects of Bordetella avium infection in the turkey respiratory tract William George Van Alstine Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Animal Sciences Commons, and the Veterinary Medicine Commons Recommended Citation Van Alstine, William George, "Structural and functional effects of Bordetella avium infection in the turkey respiratory tract " (1987). Retrospective Theses and Dissertations. 11655. https://lib.dr.iastate.edu/rtd/11655 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. INFORMATION TO USERS While the most advanced technology has been used to photograph and reproduce this manuscript, the quality of the reproduction is heavily dependent upon the quality of the material submitted. For example: • Manuscript pages may have indistinct print. In such cases, the best available copy has been filmed. • Manuscripts may not always be complete. In such cases, a note will indicate that it is not possible to obtain missing pages. • Copyrighted material may have been removed from the manuscript. In such cases, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, and charts) are photographed by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps.
    [Show full text]
  • Innate and Adaptive Immune Responses Against Bordetella Pertussis and Pseudomonas Aeruginosa in a Murine Model of Mucosal Vaccination Against Respiratory Infection
    Article Innate and Adaptive Immune Responses against Bordetella pertussis and Pseudomonas aeruginosa in a Murine Model of Mucosal Vaccination against Respiratory Infection Catherine B. Blackwood y, Emel Sen-Kilic y , Dylan T. Boehm, Jesse M. Hall, Melinda E. Varney z, Ting Y. Wong, Shelby D. Bradford, Justin R. Bevere, William T. Witt, F. Heath Damron and Mariette Barbier * West Virginia University Vaccine Development Center, Department of Microbiology, Immunology and Cell Biology, 64 Medical Center Drive, Morgantown, WV 26505, USA; [email protected] (C.B.B.); [email protected] (E.S.-K.); [email protected] (D.T.B.); [email protected] (J.M.H.); [email protected] (M.E.V.); [email protected] (T.Y.W.); [email protected] (S.D.B.); [email protected] (J.R.B.); [email protected] (W.T.W.); [email protected] (F.H.D.) * Correspondence: [email protected] The authors contributed equally. y Current affiliation: Marshall University, Department of Pharmaceutical Science and Research, One John z Marshall Drive, Huntington, WV 25755, USA. Received: 28 September 2020; Accepted: 28 October 2020; Published: 3 November 2020 Abstract: Whole cell vaccines are frequently the first generation of vaccines tested for pathogens and can inform the design of subsequent acellular or subunit vaccines. For respiratory pathogens, administration of vaccines at the mucosal surface can facilitate the generation of a localized mucosal immune response. Here, we examined the innate and vaccine-induced immune responses to infection by two respiratory pathogens: Bordetella pertussis and Pseudomonas aeruginosa. In a model of intranasal administration of whole cell vaccines (WCVs) with the adjuvant curdlan, we examined local and systemic immune responses following infection.
    [Show full text]